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Extremophiles are the organisms that survive in environments which are
inhospitable to other creatures. This thesis made an attempt to understand the
enviromental effects, in particular saline, on enzyme structure by using three dimensional
NMR. The enzyme DHFR1 from halophile Haloferaxi volcanii is complexed with its cofactor NADPH, and the saline effects on the complex are studied by comparison with its
apoenzyme, hvDHFR1. Backbone chemical shift assignments of the hvDHFR1:NADPH
complex were attained which can be functional (along with future work) in
understanding the effect of salts on enzyme structure, function, and flexibility. A total of
27 amino acids were found to show a significant change upon binding of NADPH and
their positions were identified on enzyme complex. The secondary structure of
hvDHFR1:NADPH is also predicted and overall global structure is found to be similar
with the crystal structure of hvDHFR1 with few changes.
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CHAPTER 1
ENZYME DHFR AND SALTS

1.1 Introduction
Earth has different regions that are unique to the conditions called Ecosystem.
Each ecosystem consists of different plants, animals, and organisms that have adapted to
thrive under different environmental conditions.1 Extremophiles are organisms that have
adapted to harsh environments inhospitable to other organisms.2 Halophiles are a kind of
extremophile adapted to extreme salt conditions.3 Knowing the enigma behind the
survival of halophiles could lead to new industrial and research applications. Haloferaxi
volcanii is such a species of halophile which thrives in the extreme saline conditions of
the Dead Sea.4 This work focuses on halophilic adaptation of halophile Haloferaxi
volcanii by studying its enzyme Dihydrofolate reductase (hvDHFR1).
Extremophiles survive in extreme environments which include temperature,
pressure, pH, and salt concentrations.5 Peizophiles or Barophiles survive at high
pressures (Deep Sea)6, Thermophiles,7 and Psycrophiles8 survive at high and low
temperatures respectively (volcanic springs and cold polar regions), Acidophiles9 at low
pH (pH 0-3), Alkalophiles10 at high pH (pH 10-12), and Halophiles11 at high salt
concentrations (5%-30%). Enzymes from extremophiles are used as biocatalysts in
various industries to function under non-standard conditions.12 In particular, enzymes
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like amylases,13 pullulanases,14 cyclodextrins,15 cellulases,16 xylanases,17 chitinases,18
proteinases,19 esterases,20 isomerases,21 alcohol dehydrogenases,22 and DNA-modifying
enzymes12 are used in the fields of food, chemical, pharmaceutical industries, and
environmental biotechnology.12 Amylases and pullulanases are used to improve the
industrial starch bioconversion process.23 Cellulase, the most abundant polymer in
nature, is degraded by cellulose hydrolyzing enzymes found in fungi and bacteria like
Aspergillus, Pencillium and Basisiomycetes.24 Cellulases are used in alcohol production
for improving the yield and in detergent industries for softening and particulate soil
removal.12 DNA polymerases, the key enzymes in cell replication, extracted from
extremophiles have applications in PCR (Polymerase Chain Reaction), Reverse
transcription, and DNA sequencing techniques.12 Biotechnological applications of
halophilic microorganisms has increased in recent years.25 For instance, production of ȕcarotene by Dunaliella Sp is used as anti-oxidant and food coloring agent.26 Different
carotenoid pigments produced from halobacteriaceae species are used in light absorption
and to increase evaporation in saltern ponds. Soy sauce and fish sauce are the products of
halophilic and halotolerant species.12 The extracellular polysaccharides produced from
haloferaxi species of mediterranei and volcanii are used in recovery of oil from oil
wells.27 Halophiles are not completely yet exploited and studying them further could lead
to many more industrial applications.

1.2 Halophiles
Halophiles are organisms surviving at high salt organisms. Halophiles are
grouped into three domains: Archaea, Bacteria and Eucaria. Diversity of halophiles also
2

includes oxygenic and anoxygenic phototrophs, methanogens, aerobic heterotrophs,
fermenters, denitrifiers and sulfate reducers.28 The best examples of halophilic
environments are natural inland lakes like the Dead sea29 (border of Jordan and Israel),
the Great Salt lake30 (Utah, USA), the Aral sea31 (in between Kazakhistan and
Uzbekistan), and Lake Elton32 (Russia). Halophiles are classified into slight, moderate,
and extreme halophiles depending on the concentrations of salt required for survival.

Table: 1.1
Classification of halophiles based on Kushner classification34

CLASS

HABITATION

EXAMPLES

Non-halophile

Grows best at media less
than 0.2 M salt

Most freshwater bacteria

Slight-halophile

Grows best at media having
0.2 – 0.5 M salt

Most marine bacteria

Moderate-halophile

Grows best at media having
0.5 – 0.25 M salt

Salinivibrio costicola

Grows best at media having
1.5 – 4.0 M salt

Halorhodospira halophila

Extreme halophile

Grows best at media having
2.5 – 5.2 M salt

Halobacterium salinarum

Halotolerant

It can grow in presence or
absence of salt.

Staphylococcus aureus

Borderline extreme
halophile

3

Slight halophiles grow at 0.2 to 0.85 M L-1 salt; moderate halophiles grow optimally at
concentrations of 0.85 to 3.4 M L-1 salt; and extreme halophiles from 3.4 to 5.1 M L-1
salt. Organisms that grow at less than 0.2 mol L-1 salt concentration are considered to be
non-halophilic.28, 33 Due to the wide industrial applications and diversity of halophiles,
understanding of haloadaptation could lead to a more widespread use of their enzymes.

1.3 Haloferax volcanii and DHFR
Haloferax volcanii, an extreme halophile, grows at 3.5 M salt concentration of the
Dead Sea.4 The dead Sea is located between Jordan and Israel with increasing salt
concentrations favouring halophilic adaptation. Halophiles use different mechanisms to
adapt to life at high salt. Normally, in the hypersaline environment, the cells loose water
to the surroundings through osmosis leading to the cell destruction and death of the
organism. Most of the halophiles accumulate small molecules called osmolytes inside
the cytoplasm to counteract the external osmotic pressure.35, 36 The accumulation of
osmolytes helps the cell in maintaining the turgor pressure, cell volume, and electrolyte
concentrations inside the cell. Haloferax volcanii and some other organisms use a
different strategy to adapt to saline by accumulating molar concentrations of salt equal to
the external salt concentration. This strategy involves intracellular enzyme adaptation to
the salt, as the proteins should maintain their normal conformation at near saturating salt
concentrations.37, 38 Haloferax volcanii enzymes are adapted to internal high salt, and its
enzymes require high salt for stability and activity.

4

Figure 1.1 Crystallographic Structure of Dihydrofolate reductase (DHFR)
recreated from PDB entry 5dhfr43
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Dihydrofolate reductase enzyme (DHFR, Figure 1.1) is one of the long standing
targets for enzyme studies.39 It is an essential enzyme in various biological cellular
processes including the biosyntheis of DNA.40 DHFR catalyses the reduction of
dihydrofolate (DHF) to tetra hydrofolate (THF) by using nicotinamide adenine
dinucleotide phosphate (NADPH) as a co-factor (see Figure 1.2) during which NADPH is
oxidized during the reaction.41 Tetrahydrofolate, is a precursor for purine and
thymidylate biosynthesis. Hence, it is considered to be an essential target for anticancer
drugs and antibacterial agents.42 The Escherichia coli DHFR, a gram negative bacteria, is
widly studied resulting in complete description of overall kinetic pathway.43, 45-47 These
studies provide an excellent oppurtunity to compare to the studies presented here for
hvDHFR148.

OCH 3
OCH3
NH 2
H
N
OCH3

N

H 2N

N
H

N
H

Trimethoprim

Figure 1.3 Structure of Trimethoprim

The folate metabolism is considered to be a good chemotherapeutic target, and
several antifolates had been syntheised to attack key enzymes in folate cycle. DHFR is
7

involved in the synthesis of thymidylate monophosphate (dTMP) an essential enzyme in
DNA biosynthesis and cell replication. Inhibition of DHFR leads to deficiency of dTMP
causing inhibition of cell growth.49 Trimethoprim (TMP, see Figure 1.3), Methotrexate
(MTX, see Figure 1.4), and Pyrimethamine (PYR) are regarded as the first known DHFR
inhibitors.50, 51 MTX is categorized as a “classical” antifolate with glutamate moeity
sidechain while TMP and PYR are “non classical” antifolates with out glutamate
moeity.49,52,53. Trimethoprim is used to inhibit bacterial DHFRs by blocking the
synthesis of DNA, RNA, and proteins leading to inhibition of cell growth.54 TMP is
considered to bind bacterial DHFRs 105 times greater than that of vertebrate DHFRs.55
The genome of Haloferax volcanii codes for two kinds of DHFR’s: DHFR1 and DHFR2.
DHFR1 is more halophilic than DHFR2,56 and this work deals with more halophilic
hvDHFR1 enzyme. DHFR forms complexes with folate and NADPH. NMR Structures
of hvDHFR1 and hvDHFR1:Folate complex have been previously reported.2, 3 This
thesis focuses on the binary complex of Haloferax volcanii DHFR1 and NADPH which
has not been previuosly studied by NMR.

NH 2

o
o

H
N
N

N

o
NH

o

CH3
H 2N

N

N
H

o

Methotrexate
Figure 1.4 Structure of Methotrexate
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1.4 Nicotinamide Adenine Dinucleotide Phosphate
DHFR reduces dihydrofolate to tetrahydro folate using NADPH as a co-factor
during biosyntheis of DNA. NADPH (Nicotinamide Adenine Dinucleotide Phosphate,
see Figure: 1.5) is involved in anabolic and catabolic reactions of various biological
systems. NAD and NADPH are known to be involved in more than 300 enzyme

OH
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N

N
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N
N

O

adenine

P

OH

O

NH2
H

H

HO

O

HO

N

ribose

NADPH
NADP+

H2 N

Figure 1.5 Structure of NADPH
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catalysed reactions.57-60 NADPH donates an electron to an electron acceptor such as
oxygen during electron transport in the mitochondria of cells.61 In plants, NADPH is
generated during light reactions of photosyntheis and considered as a storage form of
energy and utilised during production of carbohydrates (sugars).62 In animals, pentose
phosphate pathway (PPP) is the major source for NADPH involving in formation of
pentose sugars utilised during nucleotide and nucleoside biosynthesis.63, 64 NADPH also
involves in rate determining step of reducing 3-hydroxy-3-methylglutaryl-CoA (HMGCoA) to mevalonate in biosynthesis of Cholesterol.65 NADPH is the main source of
reduction during syntheis of aromatic compounds, steroids, alcohols and drugs.64 The
hvDHFR1 : NADPH complex is examined and results were presented towards solving the
structure of the complex for understanding halophilicity.

1.5 Effect of Salts on Activity and Stability of DHFR
The extensive review done by Eisenberg and et al. in 1994 on protein and nucleic
acid interactions with co-solvent lead to an increase in the number of publications on
halophilic proteins.66 Halophilic enzymes are defined on the basis of halophilic nature of
organism and the effect of halophilicity on its activity, stability and solubility.67 The
enzyme hvDHFR1 is active and stable at high salt concentrations of 2.5 – 3.0 M.68 As
other halophilic enzymes, hvDHFR1 enzyme possess a higher proportion of acidic amino
acids compared to the non-halophiles.69 An analysis of soluble proteins found in
halophiles showed lower Lysine and aliphatic residues and increase in small hydrophobic
amino acid content (Gly, Ala, Val) than the non-halophiles.70 Normally, high salt
concentrations increase the solubility of protein leading to destabilization of folded form
10

and vice versa.71 Thus all halophiles develop specific mechanisms to be both stable and
solubilized at high cytoplasmic KCl concentrations. Hence protein dynamics is related to
stability and activity of enzymes.72 The amino acid sequences in hvDHFR1 showed a
greater number of negatively charged groups compared to the non-halophilic homologs
(see Figure 1.6). As carboxylate groups binds to more water groups compared to the
other protein groups, these negatively charged residues are involved in hydration,
shielding the protein from aggregation. The negatively charged groups are repulsive at

hvDHFR1

1

M

E

L

V

S

V

A

A

L

A

E

N

R

V

I

G

R

D

G

E

L

P

ecDHFR

1

.

M

I

S

L

I

A

A

L

A

V

D

R

V

I

G

M

E

N

A

M

P

hvDHFR1

23

W

P

S

I

P

A

D

K

K

Q

Y

R

S

R

I

A

D

D

P

V

V

L

ecDHFR

22

W

.

N

L

P

A

D

L

A

W

F

K

R

N

T

L

N

K

P

V

I

M

hvDHFR1

45

G

R

T

T

F

E

S

M

R

D

D

L

P

G

S

A

Q

I

V

M

S

R

ecDHFR

43

G

R

H

T

W

E

S

I

G

R

P

L

P

G

R

K

N

I

I

L

S

S

hvDHFR1

67

S

E

R

S

F

S

V

D

T

A

H

R

A

A

S

V

E

E

A

V

D

I

ecDHFR

65

Q

P

G

T

D

.

.

D

R

V

T

W

V

K

S

V

D

E

A

I

.

.

hvDHFR1

89

A

A

S

L

D

A

E

T

A

Y

V

I

G

G

A

A

I

Y

A

L

F

Q

ecDHFR

83

A

A

C

G

D

V

P

E

I

M

V

I

G

G

G

R

V

Y

E

Q

F

L

hvDHFR1

111

P

H

L

D

R

M

V

L

S

R

V

P

G

E

Y

E

G

D

T

Y

Y

P

ecDHFR

105

P

K

A

Q

K

L

Y

L

T

H

I

D

A

E

V

E

G

D

T

H

F

P

hvDHFR1

133

E

W

D

A

A

E

W

E

L

D

A

E

T

D

H

E

G

F

T

L

Q

E

ecDHFR

127

D

Y

E

P

D

D

W

E

S

V

F

S

E

F

H

D

A

D

A

Q

N

S

hvDHFR1

155

W

V

R

S

A

S

S

R

ecDHFR

149

H

S

Y

C

F

E

I

L

E

R

R

Figure 1.6 Alignment of amino acid sequence of hvDHFR1 and ecDHFR. The
conserved residues in both hvDHFR1 and ecDHFR are shown in Red and
similar residues in both DHFR’s are indicated in Blue.73
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lower salt concentrations leading the protein to destabilize at less than 0.5 M salt. The
“Halophilic Stabilization model” explains that halophilic protein at higher concentrations
of salts accumulate hydrated ions on its surface with the help of specific interactions with
surface residues74 explaining the haloadaptation of many proteins.67 However, the high
resolution X-ray structures of malate dehydrogenase mutant of Haloarcula marismortui
did not supported the model completely.75 X-ray structures showed that the acidic groups
on the surface of protein are involved in binding of networks of water molecules with
specific ions that stabilize the protein which could allow for flexibility at high salt
concentrations.75 So, the role played by the surface ions in maintaining protein flexibility
and stability at high concentrations is important in understanding haloadaptation.
The effect of salts on halophilic adaptation of hvDHFR1 is examined by
comparing it with the mesophilic Eschericia coli DHFR (ecDHFR)76 as both DHFRs are
closely related. The X-ray crystallographic studies showed that Rossman fold of
hvDHFR1 is closer to the DHFRs of prokaryotic organisms like e.coli and l.casei than the
eukaryotic organisms. The hvDHFR1 has a flexible catalytic loop, L21 loop (equivalent
to M20 loop of ecDHFR) similar to that of ecDHFR.56 The activities of ecDHFR and
hvDHFR1 are examined in the presence of three different salts, KCl, NaCl, and CsCl
(See Figure 1.7).76 The ecDHFR showed maximum activity at 0 M KCl and hvDHFR1 is
highly active at 3.5 M KCl concentration at substarte concentrations of 50 µM each of
NADPH and DHF. Increase in the concentration of NaCl drastically decreased the
activity of ecDHFR. At 1.0 M salt concentration the activity of ecDHFR reduced by
more than 90% and 98% at 3.0 M KCl. The varying substarte concentrations of NADPH
and DHF also showed similar decrease in the activity of ecDHFR. This indicates that the
12

loss of activity with increase in salt concentration of ecDHFR is not by altered substrate
binding. The enzyme hvDHFR1 unlike ecDHFR showed a linear increase in activity with
increase in the concentration of KCl showing high activity at 3.0 M salt. The results were
the same with NaCl and CsCl salts.76

Figure 1.7 The percent activity of ecDHFR and hvDHFR1 with increasing salt
concentration of KCl. The ecDHFR is shown in red and hvDHFR1 in blue.
Used with permission of Dr. Lisa M. Gloss.76
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The effect of salts on the activity of hvDHFR1 and ecDHFR could be explained by
changes in the global structure, binding of substrate and flexibility. The effect of KCL on
conformational structure of hvDHFR1 is studied by Circular Dichroism (CD) and
Flouorescence (FL) spectroscopy (See Figure 1.8). The CD and FL spectra of hvDHFR1
are carried at 0.12 M and 3.0M KCl. The CD spectra of 3.0 M hvDHFR1 shows a
minimum at 212 nm and a shoulder at 225 nm indicating the presence of folded alpha
helix.77 The 0.12 M hvDHFR1 showed a decrease in the intensity of CD spectra and

Figure 1.8 The CD (red) and FL (blue) spectroscopic signal of hvDHFR1 with
increasing salt concentration of NaCl. Used with permission of Dr.Lisa M.
Gloss.76
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showed a minimum at 203 nm indicates unfolding of the enzyme. FL spectroscopy
provides information about tertiary structure of protein through tryptophan emissions.
The FL spectra of hvDHFR1 at 3.0 M salt concentration showed blue shifted emission
maxima at 335 nm indicates that Trp resides in core of the protein in hydrophobic
environment.78 The unfolded hvDHFR1 of 0.12 M showed the red shifted emission at
356 nm typical for free Trp. The effect of salt on hvDHFR1 is studied through CD and
FL signals over wide range of salt concentrations. The CD and FL signals were slightly
decreased from 3.0 to 0.5 M concentrations but decreased to a greater extent when salt
concentrations brought down below 0.5 M. At lower concentrations of KCl (< 0.5 M) the
spectral changes are constant with loss of secondary and tertiary structure. The minimal
change in the spectral signals in between 3.0 to 0.5 M indicates that unfolding is not
responsible for loss of activity of hvDHFR1.76
The activity of ecDHFR is decreased by 80 – 90% when salt concentration is
increased from 0 – 1 M. The KD (dissociation constant) values were increased by seven
and twenty fold respectively for DHF and NADPH over the same range of salt
concentrations. The KD (dissociation constant) values remained constant over 1.0 M salt.
This indicates that, the loss of ecDHFR activity over 1.0 M is not due to decrease of
ability to bind the substrate but due to loss of ability to carry out catalytic steps after
binding to the substrate and co-factor. There is no evidence indicating the unfolding of
ecDHFR protein when salt concentrations are lowered by the lack of visible precipitation
and lack of increased light scattering in UV/Vis spectra. The effect of enzyme activity is
speculated that the increase of salt promotes protein stability leading to loss of flexibility.
However, it is observed that stabilities of hvDHFR1 and ecDHFR are similar at their
15

respective physiological salt concentrations. Therefore, loss of activity of hvDHFR1 and
ecDHFR with decrease/increase of salts is not possibly due to loss of stability but due to
loss of flexibility.76 Thus to know the effect of salt concentration on flexibility of
hvDHFR1: NADPH binary complex, the structure of binary complex should be studied
for which backbone chemical shift assignments of the complex are attained through NMR
which are described in chapter 3.

1.6 Structural aspects of ecDHFR
NMR spectroscopy79, 80 and X-ray Crystallography46 have been extensively used
to study DHFR both computationally and experimentally. Dihydrofolate reductases are
small proteins mostly ranging in between 17000 – 25000 kDa. Due to the clinical role of
DHFR, it became the interest of many scientists in determining the enzyme kinetics and
structure. Major advances in DHFR are the complete kinetic pathway determinations of
e.coli,45 Pneumocystis carinii,81 mouse82 and human DHFR.83 Unfortunately most of the
extensive structural charcterisation was carried out and results were obtained for ecDHFR
(See Figure 1.9).46 The ecDHFR is a mesophile and used as a comparison to analyze the
protein structure and flexibilty of hvDHFR1.84, 85
Dihydrofolate reductases are single-domain, monomeric molecules containing
eight stranded beta (ȕ) sheet (ȕA - ȕH) flanked by two alpha(Į)-helices on either sides of
the sheet. Four helices are termed as ĮB, ĮC, ĮE and ĮF. All ȕ strands are parallel to
each other except the ȕH at the C-terminous which is an antiparallel strand. DHFRs are
organised into two sub-domains, one is the adenosine binding domain which
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binds the adenosine portion of NADPH. The major domain contains 45% of the
sequence with three loops: M20 loop, the F-G loop, and the G-H loop. A break in the
the hydrogen bonding network between the strands of E A and E E creates a gap between
the two domains forming the active site. The nicotinamide ring of NADPH spans the
active site and the pteridine ring fits in the cleft between ĮB and ĮC. The flexible, highly
conserved M20 loop (residues 10-24) shields the reactants from solvent by closing over
the active site. The conformation of this large M20 loop determines the access of the
active site to the substarte. Hence the loop movement and rotation of this M20 loop
between the two sub-domains are the main features maintaining the conformational
flexibility of DHFR.39, 46, 86-90
The ecDHFR enzyme’s M20 loop adopts four different conformations, three of
which are closed, open and occluded and fourth state is a disordered one, which is not
clearly visible in crystallographic studies (see Figure 1.10). The disordered confirmation
of M20 loop results during interconversion of the Occluded and Closed confirmations.
The conformations of M20 loop are best characterised by protein secondary structure,
hydrogen patterns with the F-G and H-G loops and the nicotinamide- ribose
interactions.39, 43 The open confiramation, an intermediate conformation between closed
and occluded form, is the frequent occuring conformation of the M20 loop. The open
confirmation of M20 loop posess no internal hydrogen bonding resulting in loss of
regular secondary structure of protein. The closed confiramation of M20 loop, packed
against the nicotinamide ring of the co-factor, is adopted when the substarte and cofactor are bound. The closed confirmation favors binding of substarte and co-factor in
the loop through hydrogen and vanderwall forces (DHFR-NADPH complex).
17
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Figure 1.9 The normal and side view of crystallographic structure of ecDHFR bounded with NADPH (Blue) and
Folate (Maroon). Recreated from PDB entry 1rx244

The active site of DHFR is protected in the closed conformation. It is the sole
confirmation seen in DHFRs of all species regardless of crystal packing and ligands
binding in the substrate and co-factor binding sites.46, 91 The occluded M20 loop inhibits
cofactor binding by occluding the nicotinamide binding site. The substrate and co-factor
binds to enzyme DHFR in closed confirmation and changes to occluded after the hydride
transfer. The central portion of M20 loop changes from a ȕ sheet to a 310 helix through
the occluded confirmation. In the occluded confirmation, the N-terminal end of the loop
is redirected resulting in the loss of hydrogen bonding with the F-G loop but it results in
formation of strong hydrogen bonding between the C-terminal and the G-H loop.46
Protein conformational differences have been studied for the binary
(ecDHFR:folate) and ternary complexes of ecDHFR.46, 92 Protein dynamics of ecDHFR
binary complex with substarte folate (ecDHFR:folate), ternary complex with folate and
5,6, dihydroNADPH (ecDHFR:folate:DHNADPH) and ternary complex with folate and
NADP+ (ecDHFR:folate:NADP+) have also been investigated. The ecDHFR:folate and
ecDHFR:folate:DHNADPH complexes adopts the occluded confirmation of M20 loop.
In the occluded confirmation, the access of nicotinamide group of co-factor is blocked by
the helix fromed from central part of M20 loop. The occluded M20 form is seen only
when nicotinamide binding loop is empty and there are no crystal packing interactions.
The occluded confirmations of both ecDHFR:folate and ecDHFR:folate:DHNADPH are
very similar. The ecDHFR:folate:NADP+ complex adopts the closed conformation of the
M20 loop with nictonimaide ring in the binding pocket. NMR relaxation studies of
ecDHFR:folate and ecDHFR:folate:DHNADPH showed increased motions on
picosecond/nanosecond time scale of M20 loop (residues 16-22), adenosine binding loop
19

Figure 1.10 The Superimposition of three different confirmations of M20 loop of
ecDHFR. Open, Closed and Occluded forms are shown in Blue, Maroon
and Green colors respectively. The PDB coded are 1ra2, 1rx2 and 1rx7
respectively.92
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(residues 67-99) and the F-G loop (residues 119-123).46 The motions of loops are evident
by decrease in S2 and increase in Ĳe values. Ĳe is the effective correlation time for internal
motions and S2 is an order parameter which describes the amplitude of intramolecular
motions of a molecule. The S2 values will be in between 0 d S2 t 1, in which lower
values indicate larger amplitude of motions.93 The closed confirmation of
ecDHFR:folate:NADP+ did not showed any motions on picosecond/nanosecond time
scale. The ecDHFR:folate:NADP+ complex showed increased S2 and decreased Ĳe values
indicating decrease of flexibilty compared to the occluded complex. In ecDHFR:folate
and ecDHFR:folate:DHNADPH complex, the residues 14-16 enter into nicotinamide
binding site making residues Met16 – Trp22 exposing to solvent. Similarly, residues
119-123 of F-G loop project out into solvent making no connections with neighbouring
groups resulting in an enhanced flexibilty in these loops. The ecDHFR:folate:NADP+
closed confirmation of M20 seals the active site by packing nicotinamide ribose moeity
in the binding site. More over, the closed confirmation is stabilized by hydrogen bonds
between M20 and the F-G loop resulting in reduced flexibility.46, 92

1.7 Structural aspects of hvDHFR1
The crystal structure of hvDHFR1 (Figure: 1.11) was first reported in 1997 and it
is the third halophilic enzyme structure which includes malate dehydrogenase and 2Fe2Fs ferredoxin of archaeon Haloarcula marismortui. The studies on halophilic enzymes
of Haloarcula marismortui showed enzyme specific bindings to salt and water in unusual
amounts and these bindings significantly reduced on denaturation.94 The hvDHFR1 is a
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Figure 1.11 The crystallographic structure of hvDHFR1. Figure recreated from PDB
entry code 1rx2.56
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monomeric enzyme containing 162 aminoacids with molecular mass of 17.9 k.Da. The
structure of hvDHFR1 contains eight ȕ strands with one antiparallel strand and four
alpha helices packing two beta sheets on either side similar to ecDHFR. The L21 loop of
hvDHFR1, analogus to M20 loop, is similar to the closed confirmation of M20 ecDHFR.
Even though the L21 loop is considered to be in the closed confirmation, the
nicotinamide binding active site is not blocked. The Į2 helix of hvDHFR1 is shifted by
2.3 Ao allowing the active site to be expose for binding of nicotinamide ribose moeity.3,
56, 95

The ecDHFR adenine moeity involves in three kinds of interactions with proteins.

It involves in vanderwall and hydrophobic interactions apart from electrostatic
interactions with Gln10. The hvDHFR1 enzyme posess Leu108 in position of Gln102 of
ecDHFR resulting in absence of electrostatic interactions in adenine moeity of
hvDHFR1.56 Bohm and Jaenickie proposed that the charge distribution of hvDHFR1 is
assymetric over the protein surface, with positively charged groups in the active site and
negatively charged groups on the opposite side of moleule.96 The crystal structure of
hvDHFR1 showed all positive charge groups closer to the nucleotide and substrate
binding site and the rest of protein is occupied by negatively charged groups.96
The NMR derived structure of hvDHFR1 is similar to the crystal structure with a
few notable differences (see Figure 1.12). The hvDHFR1 NMR structure showed eight ȕ
strands and four Į helices similar to other DHFRs. The backbone superimpose of NMR
and crystal structures of hvDHFR1 showed a root mean square deviation (RMSD) of
1.3Ao. The RMSD values should be less than 1 Ao to consider two structures for close
enough to identity. The RMSD of 1.3 Ao indicates that NMR derived structure has
deviations compared to crystal structure of hvDHFR1. The backbone superimpose of
23

Figure 1.12 NMR derived structure of hvDHFR1. Drawn from PDB code 2ITH.3
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adenosine binding domain and major domain of NMR structure with crystal structure
showed 0.83 Ao and 0.66 Ao respectively. However, a deviation of 2.3 Ao is observed
when either ends of both molecules superimposed on each other. The NMR structure
showed a difference at S59-M64 residues of ȕ3 sheet resulting in slight kink in overall
structure compared to crystal structure. The NMR structure showed NOE’s between
amide proton of A60 with both S59 and G58 and amide proton of S59 with G58 which
were not supported by the crystal structure. The crystal and NMR structures of
hvDHFR1 showed deviations in type of ȕ turn connecting ȕ7 and ȕ8. NMR structure
showed the turn as type – I ȕ turn while crystal structures defined it as type – II ȕ turn.
The presence of type – I ȕ turn in NMR structure is evident by the strong NOE between
amide proton of F150 and alpha proton of H147. The type – I ȕ turn seen in NMR
structure positions the turn in close proximity to Į1 compared to crystal structure, which
expected to play a role in binding of DHF. NMR structure of hvDHFR1 showed
difference in position of negatively charged groups of D93, E95, D114, E138 and E148
compared to crystal structure. The D93 residue is seen positioned closer to D39 and D40
residues resulting in large negative surface in NMR structure compared to crystal
structure. The large negative surfaces of halophilic proteins are expected to play an
important role in haloadaptation.3, 96
The NMR structure of the binary complex of hvDHFR1 : folate is also recently
reported. The RMSD of binary complex hvDHFR1: folate and hvDHFR1 superimpose
showed 1.70 Ao indicating the presence of deviations between the two structures. The
NMR derived structure of binary complex showed a Rossman fold with four beta sheets
of an alpha helix on either side. The loop regions of the complex did not showed
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consistency with hvDHFR1 structure. The folate and NADPH binding loops of
hvDHFR1: folate complex are showed to be disordered due to binding of substrate and
co-factor. The superimpose of Į2 helix of binary complex and hvDHFR1 indicated
increase in flexibility due to loss of some of Į structure in the folate complex. The Į2
helix of hvDHFR1: folate complex also showed decrease in number of NOEs to 53
compared to 80 in the hvDHFR1 NMR structure. The NMR structure of hvDHFR1 and
binary hvDHFR1:folate complex showed difference in hinge residues, which seperates
two domains of protein. The hvDHFR1: folate complex NMR structure also showed
slight shift of adenosine binding domain compared to major domain similar to crystal
structures of ecDHFR and NMR structure of hvDHFR1. The ecDHFR crystal structure
shows an occluded M20 confirmation when bounded to folate. The hvDHFR1 enzyme
did not showed any corresponding occluded confirmation of L21 loop when folate is
bounded to the active site. Moreover L21 loop of hvDHFR1: folate binary complex did
not showed any specific confirmation.3, 56,2

1.8 Thesis objective
Halophiles are the organisms that are adapted to high salt concentrations. The
enzymes of halophilic organisms are found to loose activity and flexibilty when salt
concentrations were lowered than optimal.56, 67 The attempts made in the past to
investigate the salt effects on haloenzymes through crystallographic46, 92 and NMR2, 3, 97
(Nuclear magnetic resonance) studies did not lead to complete understanding of
haloproteins. Hence, Dihydrofolate reductase enzyme of Haloferax volcanii is used as
model enzyme for better understanding of salt effects on halo proteins. Dihydrofolate
26

Reductase enzyme catalyzes the reaction of Dihydrofolate to Tetrahydrofolate using coenzyme NADPH. NMR has not fully exploited before to study the haloenzymes. Only
Halobacterium Salinarium ferridoxin is studied in the past at 0.45 M using NMR.97 The
extensive research done on mesophilic protein ecDHFR46, 56, 76 is used as comparitive
study for studying the halophilic protein hvDHFR1. The NMR structures of hvDHFR1
and substrate bounded hvDHFR1: folate complex have been recently reported. The
hypotheis of this research is to observe the changes in motion of binary hvDHFR1
bounded to NADPH (hvDHFR1:NADPH complex) at high salt concentrations compared
to motions of enzyme hvDHFR1 and hvDHFR1: folate complex. To understand the
dynamics of hvDHFR1:NADPH complex, the backbone chemical shift assignments must
be done which is the focus of this thesis. This research will make a step forward in
understanding the haloadaptation of enzymes and also acts like a precursor for future
studies on ternary complexes of hvDHFR1 and other DHFRs. The previous studies on
DHFR indicates the applications of DHFR in anti cancer and anti AIDS drugs.98 This
work presented here will also help in understanding the DHFR structure in better manner
thus contributing to DHFR literature and applications.

27

REFERENCES

(1)

Christopherson, R. W. Geosystems: An Introduction to Physical Geography;
Prentice Hall Inc, 1996.

(2)

Boroujerdi A.F.B, B. B., Young Y.K Biomol NMR Assign 2007.

(3)

Binbuga, B.; Boroujerdi.A.F.B.; Young, J. K. Protein Science 2007, 16, 17831787.

(4)

Cohen, S.; Shilo, M.; Kessel, M. Archives of microbiology 1991, 156, 198-203.

(5)

Pikuta, E. V.; Hoover, R. B. Critical Reviews in Microbiology 2007, 33, 183-209.

(6)

Boonyaratanakornkit, B.; Córdova, J.; Park, C. B.; Clark, D. S. Environ.
Microbiol. 2006, 8, 2031-2035.

(7)

Hensel, R.; Konig, H. FEMS Microbiol. Lett 1988, 49, 75-79.

(8)

Lonhienne, T.; Baise, E.; Feller, G.; Vouriotis, V.; Gerday, C. Biochimica et
Biophysica Acta 2001, 1545, 349-356.

(9)

Nawani, N. N.; Kapadnis, B. P.; Das, A. D.; Rao, A. S.; Mahajan, S. K. J. Appl.
Microbiol. 2002, 323, 327-344.

(10)

Hendry, P. Environ. Chem 2006, 3, 75-76.

(11)

Ricardo, C.; Torsten, T. Encylopedia of Microbiology, Second ed.; Academic
Press: Sandeigo, 2000.

(12)

Niehaus, F.; Bertoldo, C.; Kahler, M.; Antranikian, G. Appl Microbiol Biotechnol
1999, 51, 711-729.

(13)

Chung, Y. C.; Kobayashi, T.; Kanai, H.; Akiba, T.; Kudo, T. Appl Environ
Microbiol 1995, 61, 1502-1506.

(14)

Koch, R.; Canganella, F.; Hippe, H.; Jahnke, K. D.; Antranikian, G. Appl Environ
Microbiol 1997, 63, 1088-1094.

(15)

Pedersen, S.; Jensen, B. F.; Dijkhuizen, L.; Jùrgensen, S. T.; Dijkstra, B. W.
Chemtech 1995, 12, 19-25.

(16)

Teeri, T. T.; Koivula, A.; Linder, M.; Wohlfahrt, G.; Divne, C.; Jones, T. A.
Biochem Soc Trans 1998, 26, 173-178.

(17)

Winterhalter, C.; Liebl, W. Appl Environ Microbiol 1995, 61, 1810-1815.
28

(18)

Chandy, T.; Sharma, C. P. Biomater Artif Cells Artif Organs 1990, 31, 1-24.

(19)

Ladenstein, R.; Antranikian, G. Adv Biochem Eng/Biotechnol 1998, 61, 37-85.

(20)

Luthi, E.; Jasmat, N. B.; Bergquist, P. L. Appl Microbiol Biotechnol 1990, 19,
2677-2683.

(21)

Park, B. C.; Koh, S.; Chang, C.; Suh, S. W.; Lee, D. S.; Byun, S. M. Appl
Biochem Biotechnol 1997, 62, 15-27.

(22)

Ammendola, S.; Raia, C. A.; Caruso, C.; Camardella, L.; Auria, S.; DeRosa, M.;
Rossi, M. Biochemistry 1992, 31, 12514-12523.

(23)

Crabb, W. D.; Mitchinson, C. Trends Biotechnol 1997, 15, 349-352.

(24)

Tomme, P.; Warren, R. A.; Gilkes, N. R. Adv Microb Physiol 1995, 37, 1-81.

(25)

Oren, A. Journal of Industrial Microbiology & Biotechnology 2002, 28, 56-63.

(26)

Ben-Amotz, A.; Avron, M. The biotechnology of mass culturing Dunaliella for
products of commercial interest; Longman Scientific and Technical Press:
Harlow, UK, 1989.

(27)

Margesin, R.; Schinner, F. Extremophiles 2001, 5, 73-83.

(28)

DasSarma.S, A. P. Encyclopedia of Life Sciences 2001.

(29)

Al-Khlaifat, A. L. American Journal of Applied Sciences 2008, 5, 934-942.

(30)

Baxter, B. K.; Litchfield, C. D.; Sowers, K.; Griffith, J. D.; Dasarma, P. A.;
Dassarma, S. Microbial diversity of Great Salt Lake; Springer, 2005.

(31)

Khaydarov, R. A.; Khaydarov, R. R. Desalination 2007, 217, 225-232.

(32)

http://en.wikipedia.org/wiki/Lake_Elton.

(33)

Ventosa A., N. J. J., Oren A. Microbiol Mol Biol Rev 1998, 62, 504-544.

(34)

Kushner, D. J. Life in high salt and solute concentrations:halophilic bacteria;
Academic Press: London, 1978.

(35)

Galinski, E. A. Experentia 1993, 49, 487-496.

(36)

Roberts, M. F. Saline Systems 2005, 1.

(37)

Oren.A Saline Systems 2008, 4.

(38)

Oren, A. Can J Microbiol 1986, 32, 4-9.
29

(39)

Lerner, M. G.; Bowman, A. L.; Carlson, A. J. Chem. Inf. Model. 2007, 47, 23582365.

(40)

Rao, K. N.; Venkatachalam, S. K. Bioorg. Med. Chem. 1999, 7, 1105-1110.

(41)

Voet, D.; Voet, J. Aminoacid Metabolism, Second ed.; John Wiley & Sons, Inc:
Newyork, 1995.

(42)

Schweitzer, B. I.; Dicker, A. P.; Bertino, J. R. FASEB J 1990, 4, 2441-2452.

(43)

Bystroff, C.; Kraut, J. Biochemistry 1991, 30, 2227-2239.

(44)

Levin, I.; Giladi, M.; Altman-Price, N.; Ortenberg, R.; Mevarech, M. Mol.
Microbiol 2004, 54, 1307-1318.

(45)

Fierke, C. A.; Johnson, K. A.; Benkovic, S. J. Biochemistry 1987, 26, 4085-4092.

(46)

Sawaya, M. R.; Kraut, J. Bio-Chemistry 1997, 36, 586-603.

(47)

Falzone, C. J.; Cavanagh, J.; Cowart, M.; Palmer III, A. G.; Matthews, C. R.;
Benkovic, S. J.; Wright, P. E. Journal of Biomolecular NMR 1994, 4, 349-366.

(48)

Zaborowski, E.; Chung, J.; Kroon, G.; Dyson, J. H.; Wright, E. P. Journal of
Biomolecular NMR 2000, 16, 349-350.

(49)

Gangjee, A.; Kurup, S.; Namjoshi, O. Current Pharmaceutical Design 2007, 13,
609-639.

(50)

Roth, B.; Falco, E. A.; Hitchings, G. H.; Bushby, S. R. M. J Med Pharm Chem
1962, 5, 1103-1123.

(51)

Bertino, J. R. J Clin Oncol 1994, 11, 5-14.

(52)

Huennekens, F. M. Protein Science 1996, 5, 1201-1208.

(53)

Then, R. L. J. Chemother 2004, 16, 3-12.

(54)

Hawser, S.; Lociuro, S.; Islam, K. Biochemical Pharmacology 2006, 71, 941-948.

(55)

Hitchings, G. H.; Burchall, J. J. Adv Enzymol Relat Areas 1965, 27, 417-468.

(56)

Pieper, U.; Kapadia, G.; Mevarech, M.; Herzberg, O. Structure 1998, 6, 75-88.

(57)

Harrigan, T. J.; Abdullaev, I. F.; Jourd'heuil, D.; Mongin, A. A. Journal of
Neurochemistry 2008, 106, 2449-2462.

(58)

Asako, H.; Shimizu, M.; Itoh, N. Applied Microbiology and Biotechnology 2008,
80, 805-812.
30

(59)

Yang, W.; Xu, J.; Pan, J.; Xu, Y.; Wang, Z. Biochemical Engineering Journal
2008, 42, 1-5.

(60)

Sumimoto, H. FEBS Journal 2008, 275, 3249-3277.

(61)

Nelson, D. L.; Cox, M. M. Lehninger Principles of Bio-chemistry, 4th ed.; W.H.
Freeman, 2005.

(62)

Pessaraki, M., Ed. Handbook of Photosynthesis, 1st ed.; Marcel Dekker, 1996.

(63)

Csonka, L. N.; Fraenkel, D. G. The Journal of Biological Chemistry 1977, 252,
3382-3391.

(64)

Champe, P. C.; Harvey, R. A.; Ferrier, D. R. Biochemistry, Third ed.; Lippincott
Williams & Wilkins, 2004.

(65)

Vance, D. E.; Vance, J. E., Eds. Biochemistry of Lipids, Lipoproteins and
Membranes, 5th ed.; Elsevier, 2008.

(66)

Eisenberg, H.; Mevarech, M.; Zaccai, G. Adv Protein Chem 1992, 43, 1-62.

(67)

Madern, D.; Ebel, C.; Zaccai, G. Extremophiles 2000, 4, 91-98.

(68)

Christian, J. H. B.; Waltho, J. A. Biochim. Biophys. Acta 1962, 65, 506-508.

(69)

Lanyi, J. K. Bacteriol. Rev 1974, 38, 272-292.

(70)

Madern, D.; Pfister, C.; Zaccai, G. Eur J Biochem 1995, 230, 1088-1095.

(71)

von Hippel, P.; Schleich, T. Structure of Biological Molecules; Marcel Dekker
Inc: Newyork, 1969.

(72)

Lehnert, U.; Reat, V.; Weik, M.; Zaccai, G.; Pfister, C. Biophys, J. 1998, 75,
1945-1952.

(73)

Zusman, T.; Rosenshine, I.; Boehm, G.; Jaenicke, R.; Leskiw, B.; Mevarech, M.
Journal of Biological Chemistry 1989, 264, 18878-18883.

(74)

Zaccai, G.; Cendrin, F.; Haik, Y.; Borochov, N.; Eisenberg, H. J. Mol. Biol. 1989,
208, 491-500.

(75)

Richard, S. B.; Madern, D.; Garcin, E.; Zaccai, G. Biochemistry 2000, 39, 9921000.

(76)

Wright, D. B.; Banks, D. D.; Lohman, J. R.; Hilsenbeck, J. L.; Gloss, L. M. J.
Mol. Biol. 2002, 323, 327-344.

(77)

http://www.ap-lab.com/circular_dichroism.htm.
31

(78)

Sharma, V. K.; Kalonia, D. S. JOURNAL OF PHARMACEUTICAL SCIENCES
2002, 92, 890-899.

(79)

Feeney, J. Angew. Chem. Int. Ed. 2000, 39, 290-312.

(80)

Boehr, D. D.; McElheny, D.; Dyson, H. J.; Wright, P. E. Science 2006, 313, 16381642.

(81)

Margosiak, S. A.; Appleman, J. R.; Santi, D. V.; Blakley, R. L. Arch. Biochem.
Biophys. 1993, 305, 499-508

(82)

Thillet, J.; Adams, J. A.; Benkovic, S. J. Biochemistry 1990, 29, 5195-5202.

(83)

Appleman, J. R.; Beard, W. A.; Delcamp, T. J.; Prendergast, N. J.; Freisheim, J.
H.; Blakley, R. L. J. Biol. Chem. 1990, 265, 2740-2748.

(84)

Binbuga, B.; Young, J. K. Journal of Biomolecular NMR 2005, 33, 281-282.

(85)

Boroujerdi, A. F. B.; Binbuga, B.; Young, J. K. Biomol NMR Assign 2007, 1, 139141.

(86)

Hammes-Sciffer, S.; Benkovic, S. J. Annu.Rev.Biochem 2006, 75, 519-541.

(87)

Shrimpton, p.; Allemann, R. K. Protein Science 2002, 11, 1442-1451.

(88)

Li, L.; Falzone, C. J.; Wright, P. E.; Benkovic, S. J. Biochemistry 1992, 31, 78267833.

(89)

Miller, G. P.; Benkovic, S. J. Chem. Biol. 1998, 5, R105-R113.

(90)

Radkiewicz, J. L.; Brooks, C. L. J. am. Chem. Soc 2000, 122, 225-231.

(91)

Agarwal, P. K.; Billeter, S. R.; Rajagopalan, P. T. R.; Benkovic, S. J. Proc. Natl.
Acad. Sci. USA 2002, 99, 2794-2799.

(92)

Osborne, M. J.; Schnell, J.; Benkovic, S. J.; Dyson, H. J.; Wright, P. E.
Biochemistry 2001, 40, 9846-9859.

(93)

Cavanagh, J.; Fairbrother, W. J.; Palmer III, A. G.; Skelton, N. J. Protein NMR
Spectroscopy; Academic Press: San diego, 1996.

(94)

Zaccai, G.; bunick, G. J.; Eisenberg, H. J. Mol. Biol. 1986, 192, 155-157.

(95)

Binbuga, B.; Young, J. K. J. Biomol. NMR 2005, 33, 281.

(96)

Bohm, G.; Jaenicke, R. Protein Eng. 1994b, 7, 213-220.

32

(97)

Bandyopadhyay, A. K.; Krishnamoorthy, G.; Padhy, L. C.; Sonawat, H. M.
Extremophiles 2007, 11, 615-625.

(98)

Nowak, W.; Cody, V.; Wojtczak, A. Acta biochimica polonica 2001, 48, 903-916.

33

CHAPTER 2
PROTEIN PURIFICATION

2.1 Introduction
Protein structure can be determined by using Nuclear Magnetic Resonance
(NMR) Spectroscopy and Crystallographic techniques.1, 2 Analysis of the 3D structure of
a protein is a major interest of research in the biomedical community.3 Understanding
the protein structure can give clues about predicting the protein folding and its function.
Hence, to understand the effect of salt on hvDHFR:NADPH binary complex, it is
necessary to know its three dimensional structure. The advantage of NMR technique in
structural proteomics is that NMR can also be used for doing flexibility studies unlike in
crystallographic methods.
The minimum requirement for satisfactory heteronuclear NMR spectra is 99% of
isotopic label substitution in to the target protein. To achieve this, it is necessary to grow
the protein in the media having single source of these isotopes. For small sized proteins,
single labeling (15N) is sufficient for determining the structure but for proteins inbetween
12-20 KDa requires double labeling (15N and 13C) to resolve the overlapping peaks.
Proteins greater than 20 kDa require triple labeling i.e. deuterium labeling apart from 15N
and 13C.4 Replacing the hydrogen atoms with deuterium in larger proteins allows the
magnetization to spend more time on other nuclei. The NMR experiment carried out on
unlabelled protein results in delay of data acquisition as the natural abundance of NMR
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active nuclei is very low (13C – 1.1%, 15N – 0.37%). Even though the molecular weight
of hvDHFR1 is 17.2 kDa, it behaves as a 25 kDa protein in the presence of salt. Salt
increases the viscosity of solution to 1.31 cP compared to 1 cP of water at room
temperature.5 The increase in viscosity results in an increase of correlation time W

c

which is the measure of average time taken by a molecule to rotate by one radian in
solution (see equation 2-1). The NMR resonance line widths are inversely proportional
to T2 relaxation time (measure of efficiency with which the excited nuclear spins
exchange energy with each other) which decreases with increase of correlation time.6
The behavior of increase molecular weight of hvDHFR1 increases the resonance line
widths leading to problems of sensitivity and spectral overlapping.6 Hence, there is a
need of preparing triple labeled hvDHFR1 NMR sample for fast data acquisition and to
simplify the spectra.

Wc

4Sna 3
3kT

(2-1)

W c = Correlation time
Ș= Solvent Viscosity
k = Boltzman’s constant (1.38*10-23 J/K)
T= Temperature
Į = Hydrodynamic radius of protein.

The hvDHFR1 protein sample should be 95% pure in order to attain satisfactory
spectra. Hence, it should be taken care that the protein sample is devoid of unwanted
proteins and contaminations arising from sample preparation. The pH of protein and
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solvent should be ideal to physiological conditions such that protein will be in its native
and functional confirmation. It is also important that solubility of protein sample is good
enough for ideal NMR spectra with satisfactory signal to noise ratio (S/N).7

2.2 Protein extraction and purification
The DNA of hvDHFR1 for this research is provided by Dr. Lisa M. Gloss of
Washington State University.8 The DNA vector PET-11D is cloned into plasmid having
the lac promoter and transformed into Rosetta cells through transformation9 process. The
Rosetta cells with DNA of hvDHFR1 are overexpressed to achieve large quantities of
protein. The Rosetta cells with hvDHFR1 are over expressed by growing in triple labeled
M9 media. The 13C-Glucose, 15N-Ammonium chloride, and D2O were used as labeled
sources for Carbon, Nitrogen and Hydrogen respectively. The cells were grown to 0.5
O.D. and induced with IPTG to produce target hvDHFR1 protein (IPTG – isopropyl ȕ–Dthiogalactopyranoside is an artificial inducer of lac operon). The SDS PAGE gel
(Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) is used to analyze the
protein over expression. Figure 2.1 shows the over expression gel of hvDHFR1 protein
before and after inducing with IPTG. Before induction lane (middle lane) on the gel
shows no protein expression and the adjacent, after induction lane, shows corresponding
protein band indicating over expression. The left most lane of the gel represents the
marker with corresponding molecular weights mentioning adjacent to them. SDS page
gel shows other bands indicating the presence of other proteins as impurities apart from
desired protein in the sample. To attain hvDHFR1 sample with 95% purity, a sequence
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of preparative grade columns are used to purify large amounts of protein as large
concentrations of samples are necessary.
The goal of protein purification is to obtain protein in sufficient purity and
quantity needed to carry out the NMR experiments. The purification process is done in
three stages Capture, Intermediate purification and polishing.10 The capture phase of
purification is about isolating the target protein from the source. The developed
hvDHFR1 protein in host Rosetta cells is over expressed in minimal M9 media and bulk
protein is produced. The hvDHFR1 is insoluble in M9 media and thus it is denatured in
6M guanidine and refolded in 1M NaCl using the rapid refold method to activate the

M

B

A

M.W (KDa)
97.4
66.2
45.0

29.0
21.5
hvDHFR1

14.4

Figure 2.1

SDS PAGE gel showing over expression of hvDHFR1 after inducing with
IPTG.
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enzyme.11 Refolded protein in NaCl is dialysed overnight in 2.5 M (NH4)2SO4) solution.
Target protein is then isolated in pure form from the bulk by column chromatographic
technique.
Column chromatography is a powerful tool for separating mixtures. Like other
chromatographic techniques, column chromatography has stationary and mobile phase
and used in both analytical and preparative applications unlike other chromatography
techniques like paper chromatography which is used only for analytical purposes.
Column chromatography not only determines the number of components in the mixture
but also purifies substantial amounts for further analysis. Two column chromatographic
techniques are used to purify hvDHFR1 protein: Gel filtration (Intermediate purification)
and Ion-exchange chromatography (polishing).
Gel filtration chromatography also known as size exclusion chromatography
separates the proteins depending on their molecular sizes (see Figure 2.2).12 The
molecular weights of separated proteins from the solution can also be estimated through
this technique.13 Gel filtration chromatography is a two phase system: mobile and
stationary phase. Stationary phase is made up of small silica or polymer gel particles in
bead form forming a network through which solute or solvent is passed. The mobile
phase will be the same buffer in which sample protein is dissolved. Molecules are
trapped in the pores of stationary phase depending on their molecular sizes and eluted by
the flow of mobile phase. Retention time of the analytes depends on its molecular size.
The larger molecules are eluted out first as they do not suffer any retention. Smaller
molecules are diffused in to various gel pores retaining for longer time, thus eluting last.
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Therefore, eluting order of analytes is the decreasing order of their molecular sizes. It is
to be noted that gel filtration chromatography involves no physical or chemical
interactions between analytes and stationary phase unlike other chromatographic
techniques.

Mobile Phase Flow

Sample with
multiple
components
Sepharose CL-6B
beads



Figure 2.2



Diagramatic view of Gel filtration column. The different components of
sample are being separated based on their molecular sizes.

The stationary phase material used for the separation of hvDHFR1 is Sepharose
CL-6B. It has a bead diameter of 40-165 P m and fractionation range for globular
proteins is 10 – 4000 kDa.14 Sepharose is reacted with 2, 3-dibromopropanol in strong
alkaline conditions to produce cross linked agarose gel Sepharose CL. Sulphate ester
groups present in original Sepharose are removed by alkaline hydrolysis. Sepharose CL
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showed more thermal and chemical stability with low adsorption capacity than the parent
molecule.15 Figure 2.3 shows the chemical structure of Sepharose CL-6B. The
hvDHFR1 protein has more affinity towards the column material than the mobile phase
making it bind to the column at higher concentrations. Therefore, a mobile phase
gradient ranging from 2.5M to 1.25M is used to elute the protein from the column.
Figure 2.4A: shows the Ultraviolet-Visible (UV/Vis) spectra of the fractions collected
after gel filtration column. Fractions showing high absorbances in UV/Vis indicate
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Figure 2.4

The UV-Vis graph of the fraction collected after gel filtration column is
shown above (A). The SDS PAGE gel of high absorbance fractions (12-24)
is shown below (B).
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presence of protein and a SDS page gel is obtained to confirm the presence of hvDHFR1
in those fractions. Figure 2.4B: shows SDS page gel of protein fractions starting with
marker lane. SDS page shows the presence of other protein impurities along with
hvDHFR1 on gel and to attain utmost pure sample, the purified hvDHFR1 after gel
filtration is subjected to second column i.e., Ion exchange.
Ion exchange chromatography is probably the most widely used technique for the
purification of proteins, polypeptides, nucleic acids and other charged biomolecules.16-19
It holds the ions on stationary phase and exchanges them with ions in mobile phase when
brought in contact to each other (see Figure 2.5). The charged ions of protein solution are

DEAE Sephacel bead

Sample application

Gradient elution

Figure 2.5 Diagramatic view of Ion-exchange chromatography. The different
components in the sample are being seperated based on their
ionic affinity towards column
42

adsorbed onto the opposite charged surface of stationary phase through electrostatic
interactions and get desorbed by unfavoring these interactions. Firstly, the ion exchanger
is equilibrated in terms of pH and ionic strength of target molecule need to be separated.
Solute molecules in the sample when applied get adsorbed on to surface by displacing the
counter ions. The unabsorbed molecules are removed from column through washings.
The adsorbed molecules are desorbed from the column by changing the pH or ionic
strength of the eluting buffer.20 The stationary phase used for hvDHFR1 in ion exchange
chromatography is DEAE (Diethylaminoethyl)-cellulose. Structure of DEAE is showed
in Figure2.6. DEAE is prepared from high purity microcrystalline cellulose in a bead
shaped gel (40-160 µm). Cellulose is a polymer with ȕ (1,4) glucosidal linkage stabilized
by hydrogen bonding. DEAE is derivatized from positive charged amino acids making
positive charged resin which adsorbs negatively charged proteins onto the matrix.21 The
hvDHFR1 enzyme is a negatively charged protein which binds to the positive DEAE

C 2H 5

Beaded cellulose

O

CH 2

CH 2

N

+

H

Cl

C2H5

Figure 2.6 Structure of DEAE
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Figure 2.7 The UV-Vis graph of the fraction collected after Ion-exchange column is
shown above (A). The SDS PAGE gel of high absorbance fractions (1-7)
is shown below (B).
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stationary phase when applied through the column. Due to specific electrostatic
interactions of stationary phase and negative charge groups of hvDHFR1, hvDHFR1
specifically binds to DEAE matrix compared to the other proteins (impurities) in the
solution. Increasing the salt concentration (3.5 M NaCl) of the solvent unfavours the
electrostatic interaction leading to desorption of hvDHFR1 from the column matrix. The
3.5 M NaCl counter ions show high ionic interactions than the hvDHFR1 towards the
column causing desorption of hvDHFR1.22 As mentioned before the fractions showing
high UV/Vis absorbencies indicates the presence of protein hvDHFR1, which are
collected and subjected to SDS Page for confirming the presence of protein. Figure2.7
shows the SDS Page gel of the fractions collected after DEAE column. The left lane is
the marker lane with corresponding molecular weights mentioned adjacent to the gel and
the rest of the lanes showing the presence of protein in collected fractions.

2.3 15N HSQC
The SDS Page gel after DEAE column (Figure 2.7B) shows a single band
corresponding to hvDHFR1 indicating the presence of highly pure protein sample in the
fractions. All fractions having protein are pooled together and concentrated to 2 mM
optimal for an NMR sample. The co-factor NADPH is added to the sample in different
ratios and 15N-HSQC spectra are carried out to identify the optimal binding ratio. The
titration series of 15N-HSQC spectra showed that NADPH is binding to hvDHFR1
optimally at concentrations of 1:1.
The 15N-HSQC (Heteronuclear Single quantum Corelation) experiment involves
coorelation of coupled heteronuclear spins identifying directly attached nuclei.23, 24 Most
45

of the amino acids in proteins are connected through the peptide bond involving the
amide proton. A 15N-HSQC spectrum of folded protein shows well dispersed peaks
which are distinguished individually and unfolded potein shows all peaks grouped
together.7 Proline is not observed in 15N-HSQC spectrum due to lack of the amide
proton. The 15N-HSQC of hvDHFR1 is carried out before running any other NMR
experiment to determine if the signals are dispersed or not. The 15N-HSQC of the
complex showed all peaks well dispersed indicating that protein is well folded at 3.5 M
NaCl. Figure 2.8: shows 15N-HSQC spectrum of the binary hvDHFR1: NADPH
complex. The 15N-HSQC experiment is carried at 2.0 mM concentration at room
temperature on 500 MH z NMR instrument.

15

N-HSQC of hvDHFR1: NADPH is

compared with the 15N-HSQC25 of hvDHFR1 enzyme. Movement of subset of peaks in
15

N-HSQC of binary complex compared to sole hvDHFR1 indicates that NADPH is

binding to hvDHFR1.
15

15

N-HSQC of hvDHFR1: NADPH complex is also compared with

N-HSQC of hvDHFR1:folate complex26. It is observed that peaks of 15N-HSQC of

hvDHFR1: NADPH complex is showing large movement of peaks compared to the 15NHSQC peaks of hvDHFR1:Folate complex. It indicates that NADPH is binding strongly
to hvDHFR1 compared to Folate leading to more shift of the peaks. The hvDHFR1
enzyme is a 162 amino acid protein. The 15N-HSQC showed 147 peaks of total 154
expected peaks (8 prolines) and remaining of them might be over lapped with other peaks
and can not be distinguished.
The hvDHFR1 enzyme is prepared in its pure form through above mentioned
purification process. The titration series of

15

N-HSQC of hvDHFR1:NADPH binary

complex showed that the protein is folded and optimal binding of complex is at 1:1 ratio
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of enzyme and co-factor. The binding of NADPH is confirmed by the shift of subset of
peaks in 15N-HSQC of hvDHFR1:NADPH compared to 15N-HSQC of hvDHFR1 (See
Figure 2.9) and 15N-HSQC of hvDHFR1:Folate complex (See Figure 2.10). A set of three
dimensional triple resonance experiments of hvDHFR1:NADPH were carried out to
obtain backbone chemical shift assignments of this complex. The results of backbone
chemical shift assignments are discussed in the next chapter.
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Figure 2.8 The N15-HSQC of hvDHFR1:NADPH complex at 3.5 M salt
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134.0
5.2

Figure 2.9

The N15-HSQC overlays of hvDHFR1 (Blue) and hvDHFR1:NADPH binary
complex (Green) at 3.5 M salt
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Figure 2.10 The N15-HSQC overlays of hvDHFR1:Folate (Red) and hvDHFR1:NADPH
complex (Green) at 3.5 M salt
50

REFERENCES

(1)

Creighton, T. E. Proteins Structures and Molecular Properties, Second ed.; W.H.
Freeman and Company: Newyork, 1997.

(2)

Yee, A.; Chang, X.; Pineda-Lucena, A.; Wu, B.; Semesi, A.; Le, B.; Ramelot, T.;
Lee, G. M.; Bhattacharya, S.; Gutierrez, P.; Denisov, A.; Lee, C.; Cort, J. R.;
Kozlov, G.; Liao, J.; Finak, G.; Chen, L.; Wishart, W.; Lee, W.; Mcintosh, L. P.;
Gehring, K.; Kennedy, M. A.; Edwards, A. M.; Arrowsmith, C. H. Proceedings of
the national academic sciences 2002, 99, 1825-1830.

(3)

Smith, T. Nat. Struct. Biol. Suppl 2000, 7, 927.

(4)

Reid, D. G. Protein NMR Techniques; Humana press: Totowa, 1997.

(5)

Roberts, G. C. K. NMR of Macromolecules: A practical Approach; Oxford
University Pres: New York, 1993.

(6)

Wuthrich, K. NMR of Proteins and Nucleic Acids; John Wiley & Sons: New
York, 1986.

(7)

Cavanagh, J.; Fairbrother, W. J.; Palmer 111, A. G.; Skeleton, N. J. Protein NMR
Spectroscopy; Academic Press: San Diego, 1996.

(8)

Wright, D. B.; Banks, D. D.; Lohman, J. R.; Hilsenbeck, J. L.; Gloss, L. M. J.
Mol. Biol 2002, 323, 327-344.

(9)

Mandel, M.; Higa, A. J. Mol. Biol 1970, 53, 159-162.

(10)

Protein Purification, AB ed.; Amersham pharmacia biotech AB: Uppsala,
Sweden, 1999.

(11)

Blecher, O.; Goldman, S.; Mevarech, M. Eur. J. Biochem 1993, 216, 199-203.

(12)

Gel filtration principles and methods, 6th ed.; Pharmacia Biotech: Uppsala,
Sweden, 1999.

(13)

Andrews, P. Biochem, J. 1965, 96, 595-606.

(14)

http://www.sigmaaldrich.com/catalog/search/ProductDetail/SIGMA/CL6B200.

(15)

Porath, J.; Janson, J. C.; Laas, T. J. Chromatogr 1971, 60, 167-177.

(16)

Bonnerjera, J.; Oh, S.; Hoare, M.; Dunhill, P. Bio/technology 1986, 4, 954-958.
51

(17)

Kao, W. C.; Vincent, C. C.; Huang, Y.; Yu, S. S. F.; Chang, T. C.; Chan, S. I.
Journal of Inorganic Biochemistry 2008, 102, 1607-1614.

(18)

Abbas, N.; Ahmad, A.; Shakoori, A. R. Journal of Biochemistry and Molecular
Biology 2007, 40, 1002-1008.

(19)

Gusarova, V.; Vorobjeva, T.; Gusarova, D.; Lasman, V.; Bayramashvili, D.
Journal of Chromatography A 2007, 1176, 157-162.

(20)

Ion Exchange Chromatography principles and Methods, AA ed.; Pharmacia
Biotech: Uppsala, Sweden, 1999.

(21)

http://www.bio.mtu.edu/campbell/bl4820/lectures/lec6/482w61.htm.

(22)

Houwing, J.; Hateren, S. H.; Billiet, A. H.; van der Wielen, L. A. M. J.
Chromaotgr. A 2002, 952, 85-95.

(23)

Claridge, T. D. W. High-Resolution NMR Techniques in Organic Chemistry;
Elsevier: Amsterdam, 1999.

(24)

Turner, C. J.; Connolly, P. J.; Stern, A. S. Journal of Magnetic Resonance 1999,
137, 281-284.

(25)

Binbuga, B.; Young, J. K. Journal of Biomolecular NMR 2005, 33, 281-282.

(26)

Boroujerdi, A. F. B.; Binbuga, B.; Young, J. K. Biomol NMR Assign 2007, 1, 139141.

52

CHAPTER 3
BACKBONE CHEMICAL SHIFT ASSIGNMENTS OF
hvDHFR1: NADPH COMPLEX

3.1 Introduction
The knowledge of the three dimensional structure of a protein is necessary to fully
understand its complete function and applications. The three dimensional structure is
achieved through chemical shift assignments. Nuclear magnetic resonance (NMR)
techniques through multi dimensional experiments can be used to obtain the chemical
shifts of the nuclei in proteins.1 The multidimensional NMR pulse sequence exploits the
individual resonance spectrum given by each NMR active nuclei (1H, 13C, 15N). NMR
spectra are interpreted by using these individual resonances in the form of unique
chemical shifts produced by the active nuclei of the protein. Hence chemical shift
assignments play an important role in predicting the secondary structure of the protein.
Two dimensional NMR is successfully applied to proteins having up to 100 amino acids
but failed to resolve structures of proteins with greater numbers of residues due to
spectral complexity.2, 3 Normally, one or two dimensional NMR spectra of large proteins
with a high number of amino acids gives a complex spectrum with too many overlaps due
to presence of greater number of chemically equivalent nuclei. Thus, 1D and 2D NMR
are extended to the third and fourth dimensions where the signals are correlated to nuclei
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through a specific position in the molecule resulting in spectral editing. The spectral
overlap is also solved by introducing the labeled atoms 2H, 13C, 15N in to the protein.Thus
larger proteins are structurally determined by using various three dimensional NMR
techniques.
The protein NMR structural determinations mainly depend on NOEs (nuclear
Overhauser effect) generated in the NOESY spectra by the presence of active nuclei in
close proximity to each other. The presence of the NOE indicates that atoms are close to
each other in space which defines the secondary and tertiary structure of the protein. The
15

N-NOESY and 13C-NOESY gives information about amide and C-H groups of

particular amino acids closer to each other in space. The interpretation of NOESY
spectra requires backbone and side chain chemical shift assignments of the protein. Thus
a series of three dimensional NMR experiments are carried out to determine the backbone
and side chain chemical shift assignments.1, 4 The backbone chemical shifts are attained
through following experiments: HNCA,5-9 HN(CO)CA,5-9 HNCACB,7, 10, 11
CBCA(CO)HN,7, 10 HNCO,5-7 HN(CA)CO,6, 12, 13 and 15N-NOESY. This work focuses
on backbone chemical shift assignments for the hvDHFR1: NADPH binary complex.

3.2 Principle of NMR spectrum
All nuclei possess charge. NMR spectroscopy deals with the magnetic properties
associated with these charged nuclei. The charged nucleus spins around its nuclear axis
generating a magnetic field. In the presence of an external field these charged spinning
nuclei adopts specific orientations. The number of orientations is dependent on the spin
quantum number (I) of the particular nucleus. The number of possible orientations for
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any nuclei can be obtained by the equation 2I+1. For instance, the 1H (proton), 13C, 19F
nuclei have I = ½ and therefore adopts two orientations giving rise to two energy levels.
The nuclei possessing spin quantum number value more than ½, say 1, will take three
orientations possessing electric quadruples along with magnetic dipoles. The spacing
between the lines of individual peaks is called as coupling constant. The Figure 3.1
shows the typical coupling constants (1J and 2J) of amino acid residues across the peptide
backbone. The two orientations adopted by the spinning proton are: parallel (E), lower
energy state aligned with the external field; and antiparallel (D), higher energy state
opposed to the external field. There is a slight population difference in these energy
states according to the Boltzmann distribution with the lower energy state having a higher
population.15 This population difference is very small which is why NMR is referred to
as an insensitive technique. This is usually represented by a magnetization arrow in the z

Figure 3.1 The typical 1J and 2J coupling constants of an amino acid residue14
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direction which is equilibrium. In order to obtain an NMR signal, this population must
be perturbed from this equilibrium state using radio frequency pulses. The Boltzmann
relation is given as:15
ND
e 'E / kT
NE
N and N are numbers of nuclei in ground and excited states

'E is the energy difference between two states
k is Boltzmann constant; 1.3806503 × 10-23 m2 kg s-2 K-1
T is temperature
The radio pulses generally used in NMR are 90o and 180o depending on the angle
of magnetization (M) flip causing after irradiation. For example, in a 90o pulse applied
along y-axis shifts the magnetization originally on z axis by a right angle on to x-axis.
The perturbed magnetization on x-axis will precesses now in the x,y plane and relaxes
back to its original z-axis. This relaxation process is recorded and a time domain free
induction decay (FID) signal is generated. The time domain signal is converted to
frequency domain by the Fourier transformation (FT). The Fourier transformation
equation is given as:16
f(Ȧ) =  f(t) eiȦt dt
eiȦt = cos(Ȧt) + i sin(Ȧt)

The NMR spectrum is typically a plot of absorption frequency peaks versus
intensities of peaks. An example one dimensional NMR of 7 KDa protein is showed in
Figure: 3.2. The difference in the absorption position of particular 1H from the
absorption position of a standard compound is known as chemical shift of that particular
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proton. The chemical shifts are measured in į (delta) units. The chemical shift scale
(ppm) must be referenced. For protein NMR the water signal is used as a reference
therefore there is no internal reference. The one dimensional NMR spectra of

hvDHFR1:NADPH showed a few methyl protons in the negative region. The negative
chemical shifts are resulted by the methyl groups in the core of protein indicating the
folded structure of hvDHFR1:NADPH complex. The one dimensional NMR spectra is
not enough for larger proteins or other macromolecules and hence a sequence of multi
dimensional NMR experiments of hvDHFR1:NADPH complex was carried out. Each

Figure 3.2 The one dimensional NMR of 7 KDa protein.
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backbone experiment of hvDHFR1:NADPH complex is discussed in detail in the
following sections.

3.3 Backbone experiments
The backbone chemical shift assignments are the major part of NMR secondary
structure determination. A sequence of heteronuclear experiments were carried out to
achieve backbone chemical shifts. The heteronuclear experiments provide information
through resonances of labeled atoms with directly or indirectly attached nuclei. The
amino acid sequences are assigned by correlating these resonances of adjacent residues
attained from backbone experiments. The data obtained from backbone experiments is
used to achieve side chain chemical shifts. The 3D experiments used for attaining
backbone information are HNCA5-9, HN(CO)CA, HNCO, HN(CA)CO, HNCACB,
CBCA(CO)NH. The magnetization transfers of all backbone experiments are shown in
Figure: 3.3
The 3D HNCA is an important experiment in backbone chemical shift
assignments of 15N and 13C labeled proteins. It provides both intra and inter residue
13

C D carbon shifts. The magnetization of 3D HNCA involves, as the name indicates, by

transfer of magnetization from amide proton to the amide nitrogen and then to the alpha
carbon of its own residue and previous residue as shown below:
1

HNI

------>

15

1

HNI

------>

15

NI

------>

13 Į

NI
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C
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15

NI

15

NI
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1

1

HNI ( own )

HNI (previous)

Figure 3.3

The list of three dimensional triple resonance NMR backbone experiments.
The nomenclature of experiments is informative regarding the
magnetization pathway and the frequencies of nuclei detected. The nucleus
with in the bracket indicates only used as to transfer the magnetization but
its frequency is not detected. The frequencies of nuclei indicated in circles
are recorded, but not of those indicated in square boxes.5-13,17, 18
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13

The 3D HNCA experiment gives information of the CĮI,

13 Į

C

I-1,

15

N and 13C (I = ith

residue) nuclei frequencies as a cube of data. The z-axis of cube is 15N dimension, the xaxis is the 1H dimension and y-axis represents 13C chemical shifts (See Figure 3.4). The
data is analyzed by cutting the cube in the z-axis generating a set of 15N planes (normally
128) where each plane consists of correlations of different amino acids obtained by the
particular 3D pulse program. Each 15N plane generated from HNCA consists of a set of
peaks at an amide 1H chemical shift resulted from a single amino acid.

Figure 3.4 The diagrammatic view of 3D NMR cube. The figure shows a plane of data
and a strip generated from the cube.

The own and previous alpha carbon peaks of a particular amino acid are identified
by appearance of both peaks on the same 15N plane and at same amide proton chemical
13

shift of HNCA spectrum. The more intense peak corresponds to CĮI and less intense
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peak to

13 Į
C I-1.

13

The experiment is optimized to one bond coupling and thus 15N- CĮI
13

(one bond) shows high intense peak than 15N- CĮI-1 (two bond). The Figure 3.5 shows
the HNCA spectral strips connectivity of amino acids E148 to L152 of

hvDHFR1:NADPH binary complex. The strips were obtained from different 15N planes.
The more intense peak on each strip indicates the 13C resonance of its own residue and
less intense peak correlates to 13C of previous residue. A line is drawn connecting less
intense peak of each strip to more intense peak of preceding strip indicating the peptide
backbone establishment. The 13CĮ peaks of inter and intraresidual amino acids are hard to
distinguish sometimes due to overlap of both peaks or more than one amino acids carbon
alpha peak appears at same 1H chemical shift. In such cases, the 3D HN(CO)CA
experiment is used which is complimentary to HNCA since it gives information only on
the previous residues 13CĮ. The previous 13CĮ peaks (less intense) of HNCA spectrum are
confirmed by the 13C alpha residual peaks seen in HN(CO)CA. The peaks identified for
13

C alpha amino acids in HNCA and HN(CO)CA are correlated with each other and

continued along the chain establishing the complete amino acid sequence. The
magnetization in HN(CO)CA experiment is transferred from amide proton to amide
nitrogen and then to alpha carbon atom of previous residue via 13CO nuclei . The 13C
carbonyl carbon is used only to transfer the magnetization from amide nitrogen to the
previous 13CĮ and its frequency is not detected. The chemical shift resonances of alpha
carbons given by HNCA and HN(CO)CA are cross verified with each other and are
assigned to specific residues of protein sequence. The order of magnetization of
HN(CO)CA is as follows:
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Figure 3.5 Spectral strips of 3D HNCA data showing sequential correlations for
residues E148 to L152
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The backbone sequential connectivity for L152 amino acid obtained by HNCA
and HN(CO)CA experiments is shown in Figure 3.6. In the figure, the HNCA strip of
amino acid shows two peaks, more intense and less intense, corresponding to its own and
previous residues respectively. The less intense peak of HNCA strip is confirmed by
presence of a peak at the same chemical shift value in HN(CO)CA strip. A line is drawn
in the figure connecting these two peaks defining the peptide sequence between them.
The chemical shifts of the 13CĮ of all amino acids range in between 50-65 ppm
except Glycine at 45 ppm. Therefore, Glycine is a good starting point in backbone
chemical shift assignment. Two consecutive Glycines are easily found on 15N plane and
correlated back and forth to find a more intense peak of previous residue connecting the
less intense peak of Glycine. Similarly, the found less intense peak of previous Glycine
residue is correlated back and forth to find its more intense peak. This process is
continued along the chain to determine the rest of the sequence and it is showed in the
Figure 3.7. The amino acid Proline lacks the amide proton and thus do not appear on
HNCA spectrum. The presence of Proline in amino acid sequence results in break of
chemical shift assignment, in such a case a new starting point is found and process is
continued.
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HNCA
Figure 3.6

HN(CO)CA

The figure shows HNCA and HN(CO)CA strips of amino acid L152. The
less intense peak in HNCA is showing as more intense peak in its
complimentary HN(CO)CA experiment.
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The HNCA and HN(CO)CA is used to link ~75% of amino acids in the protein
sequence. The rest of amino acids are hard to distinguish as their peaks are overlapped.
Hence, to obtain near complete correlation of amino acid sequence the chemical shift
assignments are extended to the 13Cȕ nuclei. The HNCACB and CBCA(CO)HN
experiments are used complimentary to each other for obtaining beta carbon chemical
shifts. The HNCACB and CBCA(CO)HN experiment also gives information of alpha
carbons chemical shift along with beta carbons hence, it is also verifies the information
produced by HNCA and HN(CO)CA experiments. The 13Cȕ chemical shifts of amino
acids ranges from 10-80 ppm of which a few amino acids possess unique values from
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Figure 3.7 The figure shows the method followed to obtain backbone amino acid
sequence using HNCA/HN(CO)CA experiments
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O
C

which they can be identified easily in the spectrum. For example, distinctive beta
chemical shifts of Alanine at ~18 ppm, Threonine and Serine at ~70 and ~63 ppm
respectively make them distinguishable from other peaks. Glycines do not possess a beta
carbon and hence are easily identified in the spectrum. The hvDHFR1 has 21 Alanine
residues, 7 Threonine residues and 15 Serine residues which are easily distinguishable
through HNCACB and CBCA(CO)HN experiment compared to HNCA and HN(CO)CA
experiments.
The HNCACB experiment gives information of 13Cȕ and 13CĮ nuclei of both intra
and inter residual amino acids. The magnetization is transferred from the amide proton to
the amide nitrogen then to the 13C alpha and beta of its own and previous residue. Each
amide proton of amino acid couples to its own alpha more strongly (~11 Hz) than the
previous alpha carbon residues (~7 Hz) and similarly in case of coupling with beta carbon
residues. As a result, each 15N strip of HNCACB consists of two intense peaks of its own
13

CĮ and 13Cȕ and two weak peaks of the previous 13CĮ and 13Cȕ. The magnetization is

transferred in between alpha and beta carbons such that they produce peaks of opposite
signs, positive and negative, indicated in different colors. Normally 13C D peaks are
positive and shown in Black and 13Cȕ peaks are negative and shown in Red. The order of
magnetization is as follows:

1

HNI

>

------>

15

NI

------>

13 Į

C

I

------>

1

HNI ( own )
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The Figure: 3.8 shows the spectral strips of 3D HNCACB indicating D and E

carbon correlations for residues R157 to S161 obtained from different 15N planes. The
more intense peaks on each strip is due to its own alpha and beta carbon residue and less
intense peaks are resultant of previous alpha and beta carbon nuclei. The peaks showed
in Black color are negative 13Cȕ peaks and peaks showed in Green color are positive 13CĮ
peaks. A line connecting the less intense peak of each strip to more intense peak of
previous residue indicates the amino acids connectivity in hvDHFR1:NADPH complex.
The CBCA(CO)HN experiment is an complimentary experiment resolving the
ambiguities in determining the beta carbon that occurred in the HNCACB experiment. In
CBCA(CO)HN experiment the amide proton and amide nitrogen correlate to only the
previous 13CĮ and 13Cȕ nuclei generating the information pertaining to only previous
residue. The magnetization is transferred from the amide proton of previous residue to
the beta/alpha carbon then to amide nitrogen via 13C of amide group and then to amide
proton of its own. In similar to HN(CO)CA, the

13

C of amide group is used only to

transfer the magnetization and its frequency is not detected in CBCA(CO)HN
experiment. The magnetization of the experiment is as follows:
1

HȕI-1

------>

13

CĮ / 13CȕI-1

------>

13 `

C I-1

------>

15

NI

------>

1

HNI

The Figure 3.9 shows the two strips of HNCACB and CBCA(CO)HN
experiments A159 amino acid. The intense peaks in HNCACB strip at 19.8 ppm and 53.1
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Figure 3.8

Spectral strips of 3D HNCACB data showing E carbon correlations for
residues R157 to S161
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HNCACB

CBCA(CO)NH

Figure: 3.9 The figure shows HNCACB and CBCA(CO)NH correlations of amino acid
A159. The more intense peaks in HNCACB corresponds to its own residue
and less intense to previous residues. The less intense peaks in HNCACB
are showed as more intense in its complimentary CBCA(CO)NH
experiment.
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ppm correlate to its own residue and weaker peaks at 58.4 ppm and 63.8 ppm indicate
correlations of previous residue. The less intense peak of HNCACB becomes more
intense one in CBCA(CO)HN and both are indicated by drawing line in the figure. The
characteristic beta chemical shift at around 19 ppm in HNCACB indicates presence of
Alanine as its own residue and characteristic beta chemical shift at around 63.5 ppm in
HNCACB and CBCA(CO)HN strip indicates the presence of Serine as previous residue.
The chemical shift assignments are then extended to carbonyl groups which give
essential information about amino acids backbone connectivity that resolves few
ambiguities raised in previous experiments. Carbonyl chemical shift assignments were
achieved by 3D HNCO experiment. The 3D HNCO experiment correlates amide 1H and
15

N with the 13CO chemical shift of previous carbonyl group. This experiment provides

chemical shift values about previous carbonyl group residue. The magnetization in
HNCO is transferred from the amide proton to the amide nitrogen and then to the
carbonyl group of preceding residue. The order of magnetization is as follows:

1

HNI

------>

15

NI

------>

13 `

C I-1

------>

15

NI

------>

1

HNI

13

The amino acid chemical shift values of C` ranges in between 165-190 ppm. The
smaller range of chemical shift will cause overlap of peaks, in such cases the data
obtained by HNCO is supported by its complimentary experiment HN(CA)CO. The
HN(CA)CO experiment gives carbonyl chemical shift values of its own and previous
residues by transferring the magnetization from the amide proton to the amide nitrogen
and then to the own or previous alpha carbon residue via 13CO group. The 13CO of amide
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group is used only for transferring the magnetization and its frequency is not detected.
The HN(CA)CO experiment is not very useful as it involves many magnetization
transfers which do not last long for obtaining the chemical shift data. More over the
peaks corresponding to intra and inter residues in HN(CA)CO experiment are not intense
specific as in HN(CO)CA and CBCA(CO)HN experiments. For large proteins like

hvDHFR1:NADPH binary complex, the HN(CA)CO is predominantly insensitive and
therefore the

13 `

C chemical shifts are accomplished by using HNCO experiment only.

The backbone chemical shifts assignments are completely accomplished except
1

H D chemical shifts by using the above discussed triple resonance experiments: HNCA,

HN(CO)CA, HNCACB, CBCA(CO)HN and HNCO. The 1HĮ chemical shift
information is obtained by 15N-NOESY experiment. The 15N-NOESY experiment
obtains the correlations of 1HĮ through space interactions and not through bond couplings
as discussed in other experiments of this chapter. The amide proton correlates with its
own and previous 1HĮ specifically depending on its secondary structure. In the E- strand,
the amide proton correlates very weakly with its own 1HĮ and strongly with the previous
residue 1HĮ. In case of an Į-helix, amide proton correlates with its own and previous
residues in medium intensities giving rise to peaks of equal intensities. By using these
differences in intensities of peaks in E- strand and D-helix, the 1HĮ are differentiated and
chemical shift values are assigned. Once the backbone chemical shift assignments are
complete, the individual peaks in 15N-HSQC are labeled by assigning to specific amino
acid residues. The labeled 15N-HSQC is shown in Figure 3.10.
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3.4 Predicting Secondary Structure of hvDHFR1:NADPH
The protein secondary structure is strongly based on NMR chemical shifts. The
backbone chemical shift assignments can be used to describe the secondary structure of
protein through the chemical shift index.19 The chemical shift index (CSI) is a simple
NMR technique originally developed by Wishart and etal for analysis of alpha proton
chemical shifts.20 By extending chemical shift index to 13CD, 13CE and carbonyl 13C
groups, the secondary structure of hvDHFR1:NADPH binary complex is identified and
located.21 The secondary structure of proteins and peptides is possible to predict
accurately to nearly 92% by using CSI technique without the help of NOE measurements.
CSI establishes the secondary structure of a protein through chemical shift differences of
experimental and random coil values. Negative chemical shift differences of less than 0.1 for 1HD and 13CEgroups and positive chemical shift differences of more than 0.1 for
13

CDand13C` groups indicates presence of D-helix. Similarly, the positive chemical shift

differences of more than 0.1 for 1HD and 13CEgroups and negative chemical shift
differences of less than -0.1 for 13CDand13C` groups indicates presence of E-strand. The
chemical shift differences in between -0.1 and 0.1 indicates the presence of loops. The
sequences of four or more groups need to have the same deviation to predict the presence
of a helix, strand or loop. The termination points of helices and strands are identified by
the appearance of chemical shift deviation of opposite magnitude or appearance of two
consecutive loop values.20 The Figure 3.11A, 3.11B, 3.11C shows the chemical shift
deviations of 1HD, 13CE13CDand13C`, suggesting the secondary structure of

hvDHFR1:NADPH binary complex. The CSI of of hvDHFR1:NADPH complex showed
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Figure 3.10 The 15N labelled HSQC of hvDHFR1:NADPH binary complex.
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Figure 3.11A The chemical shift index of amino acids 1-54 of hvDHFR1:NADPH
binary complex suggesting the secondary structure. The swirls indicate the
alpha helix and arrows indicate E strands.
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Figure 3.11B The chemical shift index of amino acids 55-108 of hvDHFR1:NADPH
binary complex suggesting the secondary structure. The swirls indicate the
alpha helix and arrows indicate E strands.
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Figure 3.11C The chemical shift index of amino acids 109-162 of hvDHFR1:NADPH
binary complex suggesting the secondary structure. The arrows indicate E
strands.
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acids position of D2 helices andE4 strands. These slight changes might be due to the
residues interacting directly with the co-factor NADPH or due to the change in the
hydrogen bonding network of some amino acids upon the binding of NADPH to

hvDHFR1.
Chemical shift mapping is used to identify the amino acids showing different
chemical shift values in hvDHFR1: NADPH binary complex compared to apo hvDHFR1
enzyme. The chemical shift mapping is a popular technique to identify the proteinprotein or protein substrate / co-factor interactions.22 It is achieved by plotting the
differences of 15N chemical shifts Vs differences of amide proton chemical shifts of

hvDHFR1and hvDHFR1: NADPH complex. The chemical shift map is shown in Figure
3.12. The amino acids inside the circle did not show significant change in the chemical
shifts compared to hvDHFR1. The amino acids showed outside the circle are the ones
which showed significant change in their chemical shifts due to binding of NADPH to

hvDHFR1. From the figure 3.12, a total of 27 amino acids are showing significant
change in their chemical shifts of hvDHFR1: NADPH complex compared to apo enzyme.
Out of which, only 13 aminoacids are the directly interacting residues as they are
matching with the amino acids involving in binding of NADPH in ecDHFR:NADPH
complex. This indicates that the rest of the amino acids are showing change in chemical
shifts due to interaction with NADPH binding residues or due to change in the hydrogen
network upon binding of NADPH. Therefore, NADPH binding to hvDHFR1 is resulting
in the change of other few amino acids apart from binding residues. The presence of
three amino acids E6 - E7 loop (Y125, T129, D135) indicates that E6 - E7 loop is playing
significant role in binding of NADPH to hvDHFR1. The significant change showed by
77

R17 of M20 loop suggests the involvement of M20 loop in binding of NADPH to

hvDHFR1 similar to ecDHFR1:NADPH complex. The major change in a chemical shift

Figure 3.12 The chemical shift map showing the amino acids of hvDHFR1 displaying
significant change in chemical shift values upon binding to NADPH.

values of amino acids G101 – A107 indicates their presence in binding pocket and
interaction with NADPH. The Figure 3.13 shows the amino acids resulting in significant
change on apo enzyme hvDHFR1 due to NADPH binding. The amino acids indicated in
red are showing significant change in chemical shifts due to direct interaction with
NADPH. The amino acids in green are interacting with the NADPH binding residues
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and thus showing change in chemical shift values and the ones in blue are showing
change due to change in the hydrogen network of the complex.

3.5 Conclusion
The backbone chemical shift assignments of hvDHFR1:NADPH binary complex
have been accomplished. The chemical shift information of the complex can be used to
predict its secondary structure. In total, 96% of backbone chemical shift values were
achieved. In particular, 91% of 13CD, 86% of 13CE, 84% of 13CO, 97% of amide protons,
97% of amide nitrogen and 95% of 1HD are successfully assigned by using HNCA,
HN(CO)CA, HNCACB, CBCA(CO)NH, HNCO, HN(CA)CO and 15N-NOESY
experiments. The complete backbone chemical shift assignments are given in table 3.1.
The backbone chemical shifts of hvDHFR1:NADPH binary complex were compared with
apo enzyme and found few amino acids showing significant change in chemical shifts
verifying NADPH binding to enzyme. The change in chemical shifts of few amino acids
is attributed to NADPH binding to hvDHFR1. These amino acids are not only in the
NADPH binding pocket but also spread through other parts of enzyme indicating
NADPH binding affects the hydrogen binding network of the enzyme. The amino acids
affected by NADPH binding were identified and their positions were found on hvDHFR1
enzyme. The loop E6 – E7 is identified as playing role in binding of NADPH to enzyme
due to the significant change of amino acids chemical shifts in that loop. M20 loop is
found to involve in binding of NADPH to hvDHFR1 similar to of ecDHFR:NADPH
complex. A total of 27 amino acids were found to show significant change in their
chemical shifts upon binding of NADPH.
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Figure 3.13 The figure shows the amino acids of hvDHFR1 whose chemical shift
values changed significantly upon binding to NADPH. The amino acids
indicated in red are directly interacting with NADPH. The amino acids in
green are interacting with the NADPH binding residues and the ones in blue
are involving in hydrogen network of the complex. The hvDHFR1 structure
is recreated using PDB entry code 2ITH.23
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The secondary structure of hvDHFR1:NADPH binary complex is studied through
chemical shift index method. The secondary structure of the complex showed good
similarities with crystal structure of apo enzyme hvDHFR1 except few differences due to
binding of NADPH. For example, the CSI results of hvDHFR1:NADPH showed not a
well defined D2 helix and E4 strand. These differences are attributed to the binding of
NADPH to the enzyme. Thus, it indicates that NADPH binding to enzyme is altering the
position of D2 helix and E4 strands considerably and rest of the global structure of
enzyme is similar to that of apo enzyme.
The future of this research is to investigate side chain chemical shift assignments.
Then the complete chemical shift values are used in identifying NOE cross peaks. The
NOE cross peaks will enable to find the 1H – 1H distances and helps in achieving
structure calculations. The chemical shift assignment of the enzyme complex will also
predicts phi and psi dihedral angles which lead to final determination of three
dimensional protein structure. Till now attempts were made in understanding the apo
enzyme hvDHFR1 and its binary complexes with NADPH and folate by using NMR.
The ternary complex with both NADPH and folate binding to hvDHFR1 is yet to be
studied by NMR which leads in knowing hvDHFR1 enzyme completely.
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Table 3.1
Chemical shift assignments of the binary hvDHFR1:NADPH complex
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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Table 3.1 (Continued)
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CHAPTER 4
MATERIALS AND METHODS

4.1 Protein Extraction and Purification
The DNA of hvDHFR1 for this research is given by Dr. Lisa M. Gloss at
Washington State University and introduced to pET-11d expression vector.1 The pET11d vector possessing DNA of hvDHFR1 is transformed into rosetta strains of Eschericia
coli.2, 3 During transformation process, the Rosetta cells were made competent state by
treating with cold Calcium chloride followed by heating at around 42o C for brief amount
of time, during which hvDHFR1 DNA is inserted into the cells. The antibiotic used was
Chloramphenicol. The overnight incubation of Rosetta cells showed good growth on LB
agar plates with antibiotics Chloramphenicol and Ampicillin. The cells then were grown
in 3 L of nutrient rich LB (Luri-Bertani) media with appropriate volumes of antibiotics.
The antibiotics used were Chloramphenicol and Ampicillin at 34 mg/ml concentration at
a ratio of 1: 1000. The cells were grown to an optical density (O.D) of 0.5 at 600nm.
The optical density is measured on Specronic 20D spectrophotometer (Brand: Thermo
Electron). The growed cells were centrifuged at 5000 rpm for 20 minutes and collected.
The pellet is resuspended in to 1 L of triple labelled M9 media (minimal media). The
triple labeling of M9 is achieved by adding one litre of D2O for 2H source, 0.5 grams of
NH4Cl for 15N source and 2 grams of 13C glucose for 13C source. All isotopic labels were
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purchased from Cambridge isotopes. The cells were allowed to grow for one hour and
then induced with 1.5 ml of isopropyl ȕ-D-1-thiogalactopyranoside (IPTG). The cells
were again allowed to grow for overnight and subjected to centrifugation at 5000 rpm for
20 minutes and collected pellet. The protein pellet collected is stored at -800 C.
For purification, the pellet is cracked and re-suspended in 10 mM phosphate buffer
(15 ml / 2 g pellet) and a 1 mg deoxyribonuclease I (from bovine pancreas). The
dissolved pellet is sonicated for 5 times, keeping in ice bath after each sonification. The
protein solution is then centrifuged at 11000 rpm for 20 minutes at 100 C and the
precipitate is re-suspended in 6 M guanidine buffer and stirred at room temperature for
one hour. The re-suspended solution is refolded in 1 M NaCl by adding drop by drop,
waiting few seconds between each drop. The refolded solution is dialyzed overnight in
2.5 M cold ammonium sulfate 6-8 kDa cut-off membrane dialyzing tubes. The next day,
dialyzed sample is centrifuged at 11000 rpm for 15 minutes at 100 C and the supernatant
was subjected to column chromatography. The first column used was Sepharose CL-6B,
a size exclusion column. The sample is loaded manually and collected using a gradient.4
The gradient used was 100 ml of 2.5 M (NH)2SO4 to 200 ml of 1.2 M (NH)2SO4. The
fractions were collected as protein eluted and UV/Vis absorbance is measured at 280 nm
(Brand: varian). The fractions were pooled (based on SDS PAGE gel) and brought back
to 2.5 M by adding required amounts of ammonium sulfate. The pooled fractions were
next subjected to second column which is a DEAE-cellulose (diethylaminoethyl) ion
exchange column. The bounded protein to the column is eluted by running 3.5 M NaCl.
The fractions were collected and checked for UV/Vis absorbances. The presence of
protein is confirmed by subjecting the fractions to TCA precipitation followed by a SDS
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PAGE gel. The fractions having protein are pooled together and concentrated to 2 mM
using Amicon Ultra concentrators. A 15 mM NADPH in 3.5 M NaCl at a PH of 8.25 is
added to concentrated hvDHFR1 sample to make a 1:1 protein to substrate optimal
binding. 5% D2O is added to the sample to lock the deuterium during data acquisition.

4.2 NMR Data Collection
The triple resonance NMR experiments of hvDHFR1:NADPH binary complex were
performed on a 600 MHz Bruker Avance at the University of Alabama by Dr. Russell
Timkovich. The NMR raw data was processed and analyzed using NMR Pipe software5
and viewed with PIPP6 on a Silicon Graphics Octane workstation. The backbone
experiments for hvDHFR1:NADPH are collected in the following way:
HSQC: The two dimensional 1H-15N-HSQC7-8 experiment was acquired with a total of
1024 complex data points in t2 (1H) and 128 data blocks in t1 (15N). Each data block
was recorded with 32 scans at spectral widths of 9615.385 (1H) and 2150.075 Hz (15N) in
each dimension, respectively. The carrier frequencies were set to 4.785 ppm (1H) and
117.101 ppm (15N).
HNCA and HN(CO)CA: The three dimensional HNCA9-13 was acquired with a total of
1024 complex data points in t3 (1H), 64 data blocks in t2 (15N), and 128 data blocks in t1
(13C). Each data block was recorded with 32 scans at spectral widths of 9615.385 Hz
(1H), 6038.647 Hz (15N), and 4299.226 Hz (13C) in each dimension. Carrier frequencies
were set to 4.686 ppm (1H), 117.002 ppm (15N), and 59.394 ppm (13C). Data acquisition
was completed in 80 hr (3 days and 8 hr). The 3D HN(CO)CA9-13 experiment was
acquired with a total of 1024 complex data points in t3 (1H), 64 data blocks in t2 (15N),
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and 104 data blocks in t1 (13C). Each data block was recorded with 32 scans at spectral
widths of 9615.385 Hz (1H), 6038.647 Hz (15N), and 4299.296 Hz (13C) in each
dimension. The carrier frequencies were set to 4.682 ppm (1H), 116.998 ppm (15N), and
59.391 ppm (13C). Data acquisition was completed in 65 hr (2 days and 17 hr). For both
experiments, quadrature data was acquired in Echo-AnitEcho (15N) and States-TPPI
(13C) modes.
HNCACB and CBCA(CO)NH: The 3D HNCACB12,14,15 experiment was acquired with
a total of 1024 complex data points in t3 (1H), 64 data blocks in t2 (15N), and 128 data
blocks in t1 (13C). Each data block was recorded with 32 scans at spectral widths of
9615.385 Hz (1H), 11312.217 Hz (15N), and 4299.226 Hz (13C) in each dimension. The
carrier frequencies were set to 4.687 ppm (1H), 117.003 ppm (15N), and 44.399 ppm
(13C). Data acquisition was completed in 80 hr (3 days and 8 hr). The 3D
CBCA(CO)NH12,14,15 experiment was acquired with a total of 1024 complex data points
in t3 (1H), 64 data blocks in t2 (15N), and 128 data blocks in t1 (13C). Each data block
was recorded with 36 scans at 179 spectral widths of 9615.385 Hz (1H), 11312.217 Hz
(15N), and 4299.226 Hz (13C) in each dimension. The carrier frequencies were set to
4.680 ppm (1H), 116.996 ppm (15N), and 44.392 ppm (13C). Data acquisition was
completed in 90 hr (3 days and 18 hr). For both experiments, quadrature data was
acquired in Echo-AnitEcho (15N) and States-TPPI (13C) modes.
HNCO: The 3D HNCO9,12 experiment was acquired with a total of 1024 complex data
points in t3 (1H), 64 data blocks in t2 (15N), and 128 data blocks in t1 (13C). Each data
block was recorded with 24 scans at spectral widths of 9615.385 Hz (1H), 2399.808 Hz
(15N), and 4299.226 Hz (13C) in each dimension. The carrier frequencies were set to
96

4.687 ppm (1H), 116.999 ppm (15N), and 179.339 ppm (13C). Quadrature data was
acquired in Echo-AnitEcho (15N) and States-TPPI (13C) modes. The data acquisition
was completed in 60 hr (2 days and 12 hr).
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